Glycemic Control, Renal Progression, and Use of Telemedicine Phone Consultations Among Japanese Patients With Type 2 Diabetes Mellitus During the COVID-19 Pandemic: Retrospective Cohort Study.

Q2 Medicine
JMIR Diabetes Pub Date : 2023-11-21 DOI:10.2196/42607
Akiko Sankoda, Yugo Nagae, Kayo Waki, Wei Thing Sze, Koji Oba, Makiko Mieno, Masaomi Nangaku, Toshimasa Yamauchi, Kazuhiko Ohe
{"title":"Glycemic Control, Renal Progression, and Use of Telemedicine Phone Consultations Among Japanese Patients With Type 2 Diabetes Mellitus During the COVID-19 Pandemic: Retrospective Cohort Study.","authors":"Akiko Sankoda, Yugo Nagae, Kayo Waki, Wei Thing Sze, Koji Oba, Makiko Mieno, Masaomi Nangaku, Toshimasa Yamauchi, Kazuhiko Ohe","doi":"10.2196/42607","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Reduced or delayed medical follow-ups have been reported during the COVID-19 pandemic, which may lead to worsening clinical outcomes for patients with diabetes. The Japanese government granted special permission for medical institutions to use telephone consultations and other remote communication modes during the COVID-19 pandemic.</p><p><strong>Objective: </strong>We aimed to evaluate changes in the frequency of outpatient consultations, glycemic control, and renal function among patients with type 2 diabetes before and during the COVID-19 pandemic.</p><p><strong>Methods: </strong>This is a retrospective single-cohort study conducted in Tokyo, Japan, analyzing results for 3035 patients who visited the hospital regularly. We compared the frequency of outpatient consultations attended (both in person and via telemedicine phone consultation), glycated hemoglobin A<sub>1c</sub> (HbA<sub>1c</sub>), and estimated glomerular filtration rate (eGFR) among patients with type 2 diabetes mellitus during the 6 months from April 2020 to September 2020 (ie, during the COVID-19 pandemic) with those during the same period of the previous year, 2019, using Wilcoxon signed rank tests. We conducted a multivariate logistic regression analysis to identify factors related to the changes in glycemic control and eGFR. We also compared the changes in HbA<sub>1c</sub> and eGFR from 2019 to 2020 among telemedicine users and telemedicine nonusers using difference-in-differences design.</p><p><strong>Results: </strong>The overall median number of outpatient consultations attended decreased significantly from 3 (IQR 2-3) in 2019 to 2 (IQR 2-3) in 2020 (P<.001). Median HbA<sub>1c</sub> levels deteriorated, though not to a clinically significant degree (6.90%, IQR 6.47%-7.39% vs 6.95%, IQR 6.47%-7.40%; P<.001). The decline in median eGFR was greater during the year 2019-2020 compared to the year 2018-2019 (-0.9 vs -0.5 mL/min/1.73 m2; P=.01). Changes in HbA<sub>1c</sub> and eGFR did not differ between patients who used telemedicine phone consultations and those who did not. Age and HbA<sub>1c</sub> level before the pandemic were positive predictors of worsening glycemic control during the COVID-19 pandemic, whereas the number of outpatient consultations attended was identified as a negative predictor of worsening glycemic control during the pandemic.</p><p><strong>Conclusions: </strong>The COVID-19 pandemic resulted in reduced attendance of outpatient consultations among patients with type 2 diabetes, and these patients also experienced deterioration in kidney function. Difference in consultation modality (in person or by phone) did not affect glycemic control and renal progression of the patients.</p>","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":" ","pages":"e42607"},"PeriodicalIF":0.0000,"publicationDate":"2023-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10698649/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JMIR Diabetes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2196/42607","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Reduced or delayed medical follow-ups have been reported during the COVID-19 pandemic, which may lead to worsening clinical outcomes for patients with diabetes. The Japanese government granted special permission for medical institutions to use telephone consultations and other remote communication modes during the COVID-19 pandemic.

Objective: We aimed to evaluate changes in the frequency of outpatient consultations, glycemic control, and renal function among patients with type 2 diabetes before and during the COVID-19 pandemic.

Methods: This is a retrospective single-cohort study conducted in Tokyo, Japan, analyzing results for 3035 patients who visited the hospital regularly. We compared the frequency of outpatient consultations attended (both in person and via telemedicine phone consultation), glycated hemoglobin A1c (HbA1c), and estimated glomerular filtration rate (eGFR) among patients with type 2 diabetes mellitus during the 6 months from April 2020 to September 2020 (ie, during the COVID-19 pandemic) with those during the same period of the previous year, 2019, using Wilcoxon signed rank tests. We conducted a multivariate logistic regression analysis to identify factors related to the changes in glycemic control and eGFR. We also compared the changes in HbA1c and eGFR from 2019 to 2020 among telemedicine users and telemedicine nonusers using difference-in-differences design.

Results: The overall median number of outpatient consultations attended decreased significantly from 3 (IQR 2-3) in 2019 to 2 (IQR 2-3) in 2020 (P<.001). Median HbA1c levels deteriorated, though not to a clinically significant degree (6.90%, IQR 6.47%-7.39% vs 6.95%, IQR 6.47%-7.40%; P<.001). The decline in median eGFR was greater during the year 2019-2020 compared to the year 2018-2019 (-0.9 vs -0.5 mL/min/1.73 m2; P=.01). Changes in HbA1c and eGFR did not differ between patients who used telemedicine phone consultations and those who did not. Age and HbA1c level before the pandemic were positive predictors of worsening glycemic control during the COVID-19 pandemic, whereas the number of outpatient consultations attended was identified as a negative predictor of worsening glycemic control during the pandemic.

Conclusions: The COVID-19 pandemic resulted in reduced attendance of outpatient consultations among patients with type 2 diabetes, and these patients also experienced deterioration in kidney function. Difference in consultation modality (in person or by phone) did not affect glycemic control and renal progression of the patients.

在COVID-19大流行期间,日本2型糖尿病患者的血糖控制、肾脏进展和远程医疗电话咨询的使用:回顾性队列研究
背景:据报道,在2019冠状病毒病大流行期间,医疗随访减少或延迟,这可能导致糖尿病患者临床结果恶化。新冠肺炎疫情期间,日本政府特别允许医疗机构使用电话会诊等远程通信方式。目的:我们旨在评估在COVID-19大流行之前和期间2型糖尿病患者门诊就诊频率、血糖控制和肾功能的变化。方法:这是一项在日本东京进行的回顾性单队列研究,分析了3035名定期就诊的患者的结果。我们使用Wilcoxon签名rank检验,比较了2020年4月至2020年9月(即2019年COVID-19大流行期间)6个月内2型糖尿病患者的门诊会诊频率(亲自和远程医疗电话会诊)、糖化血红蛋白A1c (HbA1c)和估计肾小球滤过率(eGFR)与前一年2019年同期的情况。我们进行了多变量logistic回归分析,以确定与血糖控制和eGFR变化相关的因素。我们还使用差异中差异设计比较了远程医疗用户和非远程医疗用户2019年至2020年HbA1c和eGFR的变化。结果:总体中位门诊就诊次数从2019年的3次(IQR 2-3)显著下降至2020年的2次(IQR 2-3) (P1c水平恶化,但未达到临床显著程度(6.90%,IQR 6.47%-7.39% vs 6.95%, IQR 6.47%-7.40%;P1c和eGFR在使用远程医疗电话咨询的患者和没有使用电话咨询的患者之间没有差异。大流行前的年龄和HbA1c水平是COVID-19大流行期间血糖控制恶化的阳性预测因子,而参加门诊就诊的次数被确定为大流行期间血糖控制恶化的阴性预测因子。结论:COVID-19大流行导致2型糖尿病患者门诊就诊人数减少,这些患者也出现肾功能恶化。咨询方式(当面或电话)的差异对患者的血糖控制和肾脏进展没有影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
JMIR Diabetes
JMIR Diabetes Computer Science-Computer Science Applications
CiteScore
4.00
自引率
0.00%
发文量
35
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信